Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07587801 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vaccination Response Modulation With a Targeted Rapamycin Protocol Study

Study acronym: VON TRAPP
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 14, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study will investigate dialysis recipients' responses to important vaccines. Research suggests that a medication commonly used by transplant recipients may improve vaccine responses. The investigators will be conducting a clinical trial to see whether a short course of low-dose Sirolimus improves the response to vaccination against respiratory syncytial virus (RSV) and influenza (flu) in patient with kidney disease over 60 years old who receive haemodialysis.
Trial Details
NCT Number NCT07587801
Lead Sponsor Central Adelaide Local Health Network Incorporated
Conditions
(from sponsor)		 Vaccine Immune Response, Haemodialysis Patients, Older Adults
Related terms Influenza, Human
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov